Analyst Price Targets — GMED
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 16, 2026 2:04 pm | Richard Newitter | Truist Financial | $100.00 | $80.85 | TheFly | Globus Medical price target lowered to $100 from $115 at Truist |
| July 13, 2026 1:15 pm | Shagun Singh | RBC Capital | $115.00 | $79.53 | TheFly | Globus Medical price target lowered to $115 from $120 at RBC Capital |
| July 8, 2026 8:17 pm | — | BMO Capital | $94.00 | $76.20 | TheFly | Globus Medical initiated with an Outperform at BMO Capital |
| July 8, 2026 11:21 am | — | Stifel Nicolaus | $80.00 | $78.83 | StreetInsider | Globus Medical (GMED) PT Lowered to $80 at Stifel on 'Modest Upside Potential'Member Login |
| June 15, 2026 10:38 am | — | Piper Sandler | $100.00 | $80.39 | TheFly | Globus Medical price target lowered to $100 from $115 at Piper Sandler |
| May 8, 2026 1:46 pm | — | Needham | $117.00 | $78.77 | TheFly | Globus Medical price target raised to $117 from $114 at Needham |
| May 8, 2026 11:47 am | Larry Biegelsen | Wells Fargo | $103.00 | $85.08 | TheFly | Globus Medical price target lowered to $103 from $104 at Wells Fargo |
| February 25, 2026 2:37 pm | Richard Newitter | Truist Financial | $115.00 | $94.32 | TheFly | Globus Medical price target raised to $115 from $105 at Truist |
| January 30, 2026 11:46 am | — | Needham | $112.00 | $90.22 | TheFly | Globus Medical upgraded to Buy from Hold at Needham |
| January 26, 2026 9:39 pm | — | Cowen & Co. | $110.00 | $92.98 | TheFly | Globus Medical initiated with a Buy at TD Cowen |
Latest News for GMED
Globus Medical's 43.6% one-year rally is fueled by strong growth across both business segments, rising technology adoption and a debt-free balance sheet.
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
AUDUBON, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2026 after the market close on Thursday, August 6, 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.